Logo
x

Search category

Subscribe Now

Solid Cancers

Athenex to Acquire Kuur Therapeutics for ~$185M

Athenex to Acquire Kuur Therapeutics for ~$185M

  • May 5, 2021
Roche Signs an Agreement with Innovent to Develop Therapies for Hematological and Solid Cancers

Roche Signs an Agreement with Innovent to Develop Therapies for Hematological and Solid Cancers

  • June 9, 2020
Roche and Immatics Collaborate to Evaluate IMA101 + Tecentriq (atezolizumab) for Solid Cancers

Roche and Immatics Collaborate to Evaluate IMA101 + Tecentriq (atezolizumab) for Solid Cancers

  • February 27, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.